Envoy Medical Corporation appears in FDA premarket approval records as the applicant for P090018, the ESTEEM TOTALLY IMPLANTABLE HEARING SYSTEM, classified as an active, totally implanted middle ear hearing implant in device class 3 under product code OAF. The supplied collection holds two linked PMA records: one original approval and one 30-day notice supplement. These counts describe the supplied filings as of the snapshot date, not the company's total portfolio, sales or safety record. [1][2]

The Esteem system and its documented components

The Summary of Safety and Effectiveness Data identifies the device as an Implantable Middle Ear Hearing Device traded as Esteem®, consisting of the Sound Processor Model 2001, Sensor Model 7002, Driver Model 7502, Esteem Programmer Model 6001, Personal Programmer Model 8001, Intraoperative System Analyzer Model 3001 and accessories. The same document lists Envoy Medical Corporation as the applicant. [5]

Envoy Medical's own product page describes the Esteem® Fully Implanted Active Middle Ear Implant (FI-AMEI) as the first and only FDA-approved, fully implanted hearing device of its kind, a characterization published by the company rather than an FDA statement. [6]

Original approval and review history

FDA approved P090018 on 2010-03-17 under decision code APPR, with the application received 2009-08-04 and an expedited review flag of Y. The advisory committee was Ear, Nose, Throat, and the approval carried docket number 10M-0244 with a Federal Register notice date of 2010-05-20. [2]

The SSED records a panel recommendation date of December 18, 2009 and states that the panel voted unanimously to find the application approvable with conditions, including modification of the Indications for Use statement and use of recorded stimuli for patient speech intelligibility assessment. [5]

The 2026 manufacturing supplement

Supplement S044 was received 2026-09-18 and decided 2026-10-15 under decision code OK30 as a 30-Day Notice, with supplement reason listed as a process change involving manufacturer, sterilizer, packager or supplier. The trade name on that record is Esteem®. [1]

The supplement's approval-order statement describes revising manufacturing work instructions to add a cutting step for the feedthroughs, to address resonant frequency fatigue in the feedthrough pins, and to add an additional visual inspection step to screen for feedthrough cracks. [1]

Filing footprint and open items

The FDA PMA database page for P090018 lists a labeling document, a post-approval study report schedule and study progress link, and a series of supplements beginning with S001, S002, S003, S004, S005, S007 and S008, with a page update dated 11/09/2026. The supplied collection links only the original approval and S044. [3]

The SSED gives the applicant's address as 5000 Township Parkway, St. Paul, MN 55110, while the FDA PMA records for P090018 and S044 list 4875 White Bear Pkwy., White Bear Lake, MN 55110. Neither filing address is treated here as a verified headquarters. Ownership, parent entities, customers and commercial availability are not established by the public documents. [1][2][5]